
Keywords: prostatic neoplasms; radiotherapy; recurrence; salvage therapy; high-intensity focused ultrasound ablation; ADT; androgen deprivation therapy; BRFS; biochemical recurrence-free survival; CSS; cancer specific survival; EBRT; external beam radiotherapy; HIF